Clinical Trial Update: Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining the efficacy, safety, and predictors of response for Astragalus membranaceus in improving cognitive function in mild-to-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Astragalus membranaceus (Astragalus membranaceus)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN